# US Hydrophobic Interaction Chromatography Market > US Hydrophobic Interaction Chromatography Market Research Report: Size, Share, Trend Analysis By Product and Service (Resins, Columns, Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.67% - **2024:** $ 133.73 Million - **2025:** $ 145.32 Million - **2035:** $ 333.82 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/HC/54968-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-hydrophobic-interaction-chromatography-market-56734 --- ## Market Summary ## **US Hydrophobic Interaction Chromatography Market Overview:** As per MRFR analysis, the US Hydrophobic Interaction Chromatography Market Size was estimated at 60.15 (USD Million) in 2023. The US Hydrophobic Interaction Chromatography Market Industry is expected to grow from 64.78(USD Million) in 2024 to 171.45 (USD Million) by 2035. The US Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 9.251% during the forecast period (2025 - 2035). ### **Key US Hydrophobic Interaction Chromatography Market Trends Highlighted** Various factors drive notable trends in the US Hydrophobic Interaction Chromatography Market. One of them is the rising market demand for therapeutic monoclonal antibodies and other proteins in the biopharmaceutical industry. This is further fueled by the increasing chronic diseases coupled with an aging population, which create a need for sophisticated purification methods. Moreover, the growing research activities within the biotechnology and pharmaceutical industries are propelling the use of hydrophobic interaction chromatography due to its efficiency in biomolecules separation based on hydrophobicity. As US manufacturers focus on improving the efficiency and speed of chromatographic processes, opportunities in the US market are growing. The incorporation of robotics and other technologies into purification processes is improving productivity. In addition, the development of new chromatographic materials and application-specific resins is promising. There is an opportunity for new design solutions that reduce chemicals used in manufacturing processes and lower waste. Recently, the shift towards personalized medicine is having an impact on the US hydrophobic interaction chromatography market. As therapies become more individualized, there is a greater need for flexible and accurate purification strategies. Policies relaxing the approval processes for biopharmaceuticals are accelerating market growth which demonstrates positive growth conditions for chromatography R&D. In general, the US Hydrophobic Interaction Chromatography Market is set to grow with increasing technology and changes in the biopharmaceutical field. ## **US Hydrophobic Interaction Chromatography Market Drivers** ### **Increasing Demand for Biopharmaceuticals** The growing demand for biopharmaceuticals in the US is a significant driver for the US Hydrophobic Interaction Chromatography Market Industry. According to the Food and Drug Administration (FDA), the biopharmaceutical industry has seen an annual growth rate of 7.4% over the last five years, highlighting the increasing focus on biologics that require advanced purification processes. Companies such as Amgen and Genentech are leading this charge, demanding more efficient and refined chromatography techniques to enhance product yield and purity.As the US population ages, the need for effective treatments for chronic diseases will increase, thus propelling the need for Hydrophobic Interaction Chromatography technologies. With a projected rise in market valuation, this segment will significantly contribute to the growth of the chromatography market as key players continue to invest heavily in Research and Development to create innovative solutions tailored to biopharmaceutical applications. ### **Technological Advancements in Chromatography** Ongoing technological advancements in chromatography are poised to accelerate the growth of the US Hydrophobic Interaction Chromatography Market Industry. Trends indicate that automation and high-throughput screening capabilities are becoming industry standards, thereby enhancing the efficiency of chromatography processes. The American Chemical Society reports a rise in patent applications related to chromatography innovations, signaling robust Research and Development efforts. Companies like Waters Corporation and GE Healthcare are already adopting these advancements, leading to improved resolutions and faster separation times. This ongoing evolution in chromatography technology will cater to the increasing complexities in biomolecule separation, driving market growth significantly in the coming years. ### **Rising Incidence of Chronic Diseases** The increasing incidence of chronic diseases such as diabetes, cancer, and autoimmune disorders is another vital driver of the US Hydrophobic Interaction Chromatography Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the United States have a chronic disease, underlining the urgent need for effective therapies. This escalating healthcare burden prompts pharmaceutical companies to invest in advanced separation techniques like Hydrophobic Interaction Chromatography to develop and deliver effective medications.Major pharmaceutical players such as Pfizer and Merck recognize this need and are expanding their product lines to address chronic conditions, thereby leading to increased demands for enhanced chromatography capabilities. ### **Supportive Government Policies and Funding** Supportive government policies and funding initiatives have a remarkable impact on the growth of the US Hydrophobic Interaction Chromatography Market Industry. The National Institutes of Health (NIH) has significantly increased its funding for biotechnology research, reaching nearly $42 billion in 2021, which facilitates extensive Research and Development in chromatography applications. This government backing propels innovations and supports the establishment of startups and established companies alike, creating a conducive environment for market expansion. Initiatives like the 21st Century Cures Act also promote the fast-tracking of breakthrough therapies and diagnostics, further ensuring that advanced chromatography methods can be utilized efficiently in biopharmaceutical manufacturing. ## **US Hydrophobic Interaction Chromatography Market Segment Insights:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The Product and Service segment of the US Hydrophobic Interaction Chromatography Market encompasses a variety of components essential for effective chromatographic separation, including Resins, Columns, Services, and Other offerings. Resins play a crucial role in this segment as they determine the affinity and performance of the chromatographic process; different types of resins cater to various applications, making them a focal point for product innovations. Columns, which house the resin and facilitate the separation process, are vital for optimizing the chromatographic conditions to enhance purity and yield. The Services offered within this market are significant as they cover a range of support before, during, and after the chromatography process, from technical assistance to maintenance and calibration of equipment, ensuring reliable operations. The Other category can include ancillary products such as reagent kits and online monitoring systems that contribute to the overall effectiveness of hydrophobic interaction chromatography. As the biopharmaceutical sector continues to grow in the US, driven by an increasing demand for biologics, the importance of these products and services is heightened, presenting numerous opportunities for market players to enhance their offerings and leverage advancements in technology.The demand for high purity and effective separation methods fuels innovation in the resins and column design, thus driving market growth in this segment. The landscape of this segment is evolving, with an increasing trend towards automated solutions and integrated systems that enhance workflow efficiency and reliability. Overall, the Product and Service segment within the US Hydrophobic Interaction Chromatography Market remains a dynamic landscape, significantly influencing the broader market trends and highlighting the critical role of various components in achieving successful chromatography outcomes. ## **US Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights:** The US Hydrophobic Interaction Chromatography Market has seen significant developments driven by increasing demands in biopharmaceutical processes, protein purification, and the growing focus on personalized medicine. Competitive insights reveal a landscape populated by various players leveraging innovation and technology to enhance their offerings. Market participants are focused on research and development, striving to refine their chromatography systems and improve efficiency and resolution for diverse applications. As companies in this domain expand their portfolios and enhance their market positioning, understanding strategic movements, product launches, and technological advancements is crucial to deciphering the competitive nuances shaping the market.Agilent Technologies is recognized as a formidable player in the US Hydrophobic Interaction Chromatography Market, primarily due to its state-of-the-art technology and extensive expertise in analytical systems. The company is well-regarded for its commitment to quality and innovation, producing advanced chromatography solutions that cater to a wide range of applications including protein purification and biomolecule analysis. Agilent Technologies boasts an impressive customer base, supported by its robust distribution network that spans various regions within the US. Additionally, the company frequently updates its product lines, showcasing a strength in flexibility and responsiveness to the ever-evolving market demands which bolsters its competitive edge significantly against other market players.Cytiva, another key player in the US Hydrophobic Interaction Chromatography Market, maintains a strong presence owing to its extensive range of bioprocessing products and services, which include tools for protein purification and cell culture. Known for its innovative solutions, Cytiva emphasizes high quality and reliability in its offerings, catering to the biopharmaceutical sector's unique needs. The company has expanded its market presence through strategic partnerships and collaborations that enhance its capabilities and technological advancements. Additionally, Cytiva has sought growth through mergers and acquisitions, enabling broader access to a diverse customer base seeking cutting-edge chromatography solutions tailored for protein purification and bioprocessing demands. By consistently aligning its product development with market trends, Cytiva solidifies its strengths within the competitive landscape of the US Hydrophobic Interaction Chromatography Market. ### **Key Companies in the US Hydrophobic Interaction Chromatography Market Include:** - Agilent Technologies - Cytiva - Roche Diagnostics - Merck KGaA - Waters Corporation - Pall Corporation - Eppendorf - BioRad Laboratories - Tosoh Bioscience - Fresenius Kabi - Thermo Fisher Scientific - GE Healthcare - Nuvia - SigmaAldrich - PerkinElmer ## **US Hydrophobic Interaction Chromatography Market Industry Developments** The US Hydrophobic Interaction Chromatography Market has witnessed significant developments recently. Agilent Technologies and Merck KGaA have been involved in expanding their product portfolios, enhancing their market positions with new offerings aimed at improving efficiency in biomolecule separation. In September 2023, Cytiva announced advancements in their chromatography solutions, which are designed to promote better scalability for therapeutic protein production. Moreover, in August 2023, a noteworthy merger occurred as Thermo Fisher Scientific acquired a biotechnology firm specializing in nanotechnology, further broadening their chromatography capabilities.  Recent market valuations indicate a steady growth trajectory of approximately 8% annually, driven by increased demand for biopharmaceutical production, notably in monoclonal antibodies and vaccines. Waters Corporation and BioRad Laboratories are also investing heavily in Research and Development to innovate product offerings catering to regulatory requirements. Between 2021 and 2023, the market has been influenced by a growing focus on precision medicine, which has been gradually reshaping the chromatography landscape, increasing the importance of hydrophobic interaction chromatography as a key separation technique. This trend has been marked by rising collaborations between leading firms to advance their technological capabilities and customer outreach. ## **Hydrophobic Interaction Chromatography Market Segmentation Insights** - ### **Hydrophobic Interaction Chromatography Market Product and Service Outlook** - **Resins** - **Columns** - **Services** - **Others** ## Market Drivers ### Growing Focus on Quality Control Quality control remains a pivotal aspect of the hydrophobic interaction-chromatography market, particularly in the biopharmaceutical industry. With stringent regulatory requirements in place, companies are compelled to implement robust purification processes to ensure product safety and efficacy. The hydrophobic interaction-chromatography market is likely to thrive as organizations prioritize compliance with Good Manufacturing Practices (GMP) and other quality standards. In 2025, the emphasis on quality assurance is expected to drive investments in advanced chromatographic systems, which can provide reproducible results and high purity levels. This focus on quality control not only enhances product integrity but also strengthens consumer trust, thereby supporting the growth of the hydrophobic interaction-chromatography market. ### Rising Biopharmaceutical Production The hydrophobic interaction-chromatography market is experiencing growth due to the increasing production of biopharmaceuticals. As the demand for biologics rises, manufacturers are seeking efficient purification methods to ensure product quality. In 2025, the biopharmaceutical sector is projected to reach a valuation of over $300 billion in the US, driving the need for advanced chromatographic techniques. Hydrophobic interaction-chromatography offers a reliable solution for separating proteins and other biomolecules, which is essential for the development of therapeutics. This trend indicates a robust market for hydrophobic interaction-chromatography systems, as companies invest in technologies that enhance yield and purity. Furthermore, the shift towards personalized medicine necessitates the use of sophisticated purification methods, further propelling the hydrophobic interaction-chromatography market. ### Emerging Applications in Diagnostics The hydrophobic interaction-chromatography market is witnessing new opportunities due to emerging applications in diagnostics. As the healthcare landscape evolves, there is a growing need for precise and efficient methods to analyze biomolecules. Hydrophobic interaction-chromatography is increasingly utilized in diagnostic assays, particularly for protein characterization and biomarker discovery. The US diagnostic market is projected to reach $100 billion by 2025, indicating a substantial demand for reliable purification techniques. This trend suggests that the hydrophobic interaction-chromatography market could expand as diagnostic companies seek to enhance their analytical capabilities. The integration of these techniques into diagnostic workflows may lead to improved patient outcomes and more effective disease management. ### Advancements in Chromatography Technology Technological advancements play a crucial role in shaping the hydrophobic interaction-chromatography market. Innovations in chromatography equipment and methodologies are enhancing the efficiency and effectiveness of purification processes. In 2025, the introduction of next-generation chromatographic systems is expected to streamline workflows and reduce operational costs for manufacturers. These advancements may include improved resin technologies, automation, and real-time monitoring capabilities, which collectively enhance the performance of hydrophobic interaction-chromatography. As companies strive for higher throughput and lower production costs, the adoption of these advanced technologies is likely to drive growth in the hydrophobic interaction-chromatography market. This trend indicates a dynamic landscape where continuous improvement is essential for maintaining competitive advantage. ### Increased Research and Development Activities The hydrophobic interaction-chromatography market is benefiting from heightened research and development activities across various sectors, particularly in pharmaceuticals and biotechnology. In 2025, R&D spending in the US is expected to exceed $600 billion, with a significant portion allocated to drug development and protein engineering. This surge in investment fosters innovation in purification technologies, including hydrophobic interaction-chromatography, which is crucial for isolating complex biomolecules. As researchers strive to develop novel therapeutics, the demand for efficient and scalable purification methods is likely to increase. Consequently, the hydrophobic interaction-chromatography market is positioned to expand as laboratories and manufacturing facilities adopt these advanced techniques to meet their R&D objectives. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) is projected to grow at an 8.67% CAGR from 2025 to 2035, driven by increasing demand for biopharmaceuticals and advancements in chromatography technologies. **New opportunities:** - Development of high-throughput screening systems for rapid analysis. - Expansion of customized resin solutions for specific applications. - Integration of automation in chromatography processes to enhance efficiency. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic advancements. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Buffers (Fastest-Growing) In the US hydrophobic interaction-chromatography market, resins dominate the product and service segment, commanding a significant share due to their critical role in purification processes. Other key contributors include columns and buffers, each contributing to the overall efficiency and effectiveness of chromatography. Notably, buffers are emerging as a rapidly growing segment, driven by innovations in formulation and an increased demand for high-quality separation processes. The growth trends in this market segment are primarily influenced by advancements in biopharmaceutical development, requiring robust and reliable chromatography solutions. Furthermore, the increasing adoption of automation and efficient workflows in laboratories is facilitating the expansion of various products, particularly buffers which enhance process performance. As regulatory standards become more stringent, the necessity for high-performance reagents is propelling this segment forward, ensuring continual growth and innovation. Resins (Dominant) vs. Buffers (Emerging) Resins are recognized as the dominant force within the product and service segment of the US hydrophobic interaction-chromatography market, providing essential functionalities for various purification applications. Their versatile nature allows them to be employed in a wide range of processes, contributing to their strong market presence. These materials often exhibit high binding capacities and specialized attributes tailored for specific target molecules. On the other hand, buffers are emerging as a vital component in the chromatography process, particularly due to their role in maintaining optimal pH and ionic strength, which are crucial for effective separation. The growing emphasis on bioproduction efficiency is enhancing the popularity of purpose-developed buffers, leading to a dynamic shift in market demand and opportunity. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Vaccines (Fastest-Growing) The market share distribution in the US hydrophobic interaction-chromatography market reveals that monoclonal antibodies hold the largest share, reflecting a strong demand from biopharmaceuticals and therapeutics. This segment's dominance is fueled by the increasing investment in antibody therapies and the need for high-purity proteins in research and development. Conversely, vaccines are gaining traction, representing a rapidly growing segment as public health initiatives and new vaccine formulations push for innovative processes that enhance yield and purity. As growth trends indicate, the monoclonal antibodies segment is showing steady increases, driven by robust pipeline developments and commercialization activities. The vaccines segment, however, is projected to grow at the fastest rate, motivated by advancements in vaccine technologies and heightened public interest in vaccination programs. This growth is further supported by increased funding for research and development, coupled with the ongoing need for effective vaccines which can result in a significant expansion of production capabilities. Monoclonal Antibodies (Dominant) vs. Vaccines (Emerging) Monoclonal antibodies dominate the US hydrophobic interaction-chromatography market due to their widespread use in therapeutic applications and extensive research backing. Highly specific in their action, they provide significant therapeutic advantages, thereby driving high demand. The emerging vaccines segment, on the other hand, is characterized by rapid innovation, focusing on novel delivery systems and adjuvants to enhance efficacy. While monoclonal antibodies are recognized for their proven track record, vaccines are gaining momentum as they adapt to meet contemporary health challenges, indicating a dynamic landscape where both segments play crucial roles in biopharmaceutical progress. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations & Contract Manufacturing Organizations (Fastest-Growing) The US hydrophobic interaction-chromatography market exhibits a diverse range of end-users, with Pharmaceutical & Biopharmaceutical Companies currently holding the largest market share. This segment is primarily driven by the increasing demand for innovative therapies and biologics that necessitate effective purification processes. In contrast, Contract Research Organizations & Contract Manufacturing Organizations constitute the fastest-growing segment due to the rising trend of outsourcing in drug development and manufacturing, which significantly boosts the usage of advanced methodologies like hydrophobic interaction-chromatography. The growth trends within this sector indicate a robust expansion driven by technological advancements and increasing R&D investments. Pharmaceutical & Biopharmaceutical Companies are focusing on enhancing production efficiency and product purity, fueling the demand for sophisticated chromatography solutions. Meanwhile, the growing awareness and adoption of process optimization by Contract Research Organizations & Contract Manufacturing Organizations are propelling their growth, leading to a significant shift in market dynamics favoring these entities. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations & Contract Manufacturing Organizations (Emerging) Pharmaceutical & Biopharmaceutical Companies are the dominant force in the US hydrophobic interaction-chromatography market, leveraging advanced techniques to ensure the purification of complex biomolecules. This segment emphasizes quality and efficiency, implementing innovative chromatography solutions to meet regulatory standards. On the other hand, Contract Research Organizations & Contract Manufacturing Organizations are emerging as key players, driven by an increase in outsourcing practices. These organizations focus on providing specialized services, adopting hydrophobic interaction-chromatography to enhance the purification process in drug development. The adaptability and responsiveness of these emerging entities towards market needs position them well for rapid growth, making them critical contributors to the evolving landscape of the hydrophobic interaction-chromatography sector. ## Competitive Benchmarking The hydrophobic interaction-chromatography market is currently characterized by a dynamic competitive landscape, driven by increasing demand for biopharmaceuticals and advancements in protein purification technologies. Key players such as GE Healthcare (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories (US) are strategically positioned to leverage their extensive product portfolios and innovative capabilities. GE Healthcare (US) focuses on enhancing its chromatography systems through continuous innovation, while Thermo Fisher Scientific (US) emphasizes strategic partnerships to expand its market reach. Bio-Rad Laboratories (US) is actively investing in R&D to develop next-generation chromatography solutions, thereby shaping a competitive environment that prioritizes technological advancement and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive trends in product development and market expansion. This competitive structure suggests that while individual companies may have distinct strategies, their actions collectively influence market dynamics and customer preferences. In October Thermo Fisher Scientific (US) announced a collaboration with a leading biopharmaceutical company to develop a new line of chromatography resins tailored for monoclonal antibody purification. This strategic move is likely to enhance Thermo Fisher's product offerings and strengthen its position in the biopharmaceutical sector, where demand for efficient purification processes is surging. The collaboration underscores the importance of partnerships in driving innovation and meeting evolving customer needs. In September Bio-Rad Laboratories (US) launched a new high-performance chromatography system designed to improve the efficiency of protein purification workflows. This introduction is significant as it reflects Bio-Rad's commitment to advancing chromatography technology and addressing the growing need for faster and more reliable purification methods. The launch is expected to attract a diverse customer base, further solidifying Bio-Rad's competitive stance in the market. In November GE Healthcare (US) unveiled a new digital platform that integrates AI-driven analytics into its chromatography systems. This development is indicative of the ongoing trend towards digitalization in the industry, as companies seek to enhance operational efficiency and provide data-driven insights to customers. The integration of AI is likely to set GE Healthcare apart from competitors, positioning it as a leader in the digital transformation of chromatography solutions. As of November current competitive trends in the hydrophobic interaction-chromatography market include a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize these aspects will likely gain a competitive edge in the market. ## Recent News & Developments The US Hydrophobic Interaction Chromatography Market has witnessed significant developments recently. Agilent Technologies and Merck KGaA have been involved in expanding their product portfolios, enhancing their market positions with new offerings aimed at improving efficiency in biomolecule separation. In September 2023, Cytiva announced advancements in their chromatography solutions, which are designed to promote better scalability for therapeutic protein production. Moreover, in August 2023, a noteworthy merger occurred as Thermo Fisher Scientific acquired a biotechnology firm specializing in nanotechnology, further broadening their chromatography capabilities.  Recent market valuations indicate a steady growth trajectory of approximately 8% annually, driven by increased demand for biopharmaceutical production, notably in monoclonal antibodies and vaccines. Waters Corporation and BioRad Laboratories are also investing heavily in Research and Development to innovate product offerings catering to regulatory requirements. Between 2021 and 2023, the market has been influenced by a growing focus on precision medicine, which has been gradually reshaping the chromatography landscape, increasing the importance of hydrophobic interaction chromatography as a key separation technique. This trend has been marked by rising collaborations between leading firms to advance their technological capabilities and customer outreach. ## Report Scope | MARKET SIZE 2024 | 133.73(USD Million) | | --- | --- | | MARKET SIZE 2025 | 145.32(USD Million) | | MARKET SIZE 2035 | 333.82(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.67% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Advancements in biopharmaceuticals drive demand for innovative hydrophobic interaction-chromatography solutions. | | Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation and competition in hydrophobic interaction-chromatography technologies. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US hydrophobic interaction-chromatography market in 2024?** A: The market valuation was $133.73 Million in 2024. **Q: What is the projected market valuation for the US hydrophobic interaction-chromatography market by 2035?** A: The projected valuation for 2035 is $333.82 Million. **Q: What is the expected CAGR for the US hydrophobic interaction-chromatography market during the forecast period 2025 - 2035?** A: The expected CAGR is 8.67% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the US hydrophobic interaction-chromatography market?** A: Key players include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Agilent Technologies, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the US hydrophobic interaction-chromatography market?** A: Main product segments include Resins, Columns, Buffers, and Other Products and Services. **Q: What was the valuation range for Resins in the US hydrophobic interaction-chromatography market?** A: The valuation range for Resins was $40.0 Million to $100.0 Million. **Q: What sample types are primarily analyzed in the US hydrophobic interaction-chromatography market?** A: Primary sample types include Monoclonal Antibodies, Vaccines, and Others. **Q: What was the valuation range for Monoclonal Antibodies in the US hydrophobic interaction-chromatography market?** A: The valuation range for Monoclonal Antibodies was $60.0 Million to $150.0 Million. **Q: Who are the primary end-users of hydrophobic interaction-chromatography products in the US market?** A: Primary end-users include Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, and Research & Academic Institutes. **Q: What was the valuation range for Pharmaceutical & Biopharmaceutical Companies in the US hydrophobic interaction-chromatography market?** A: The valuation range for Pharmaceutical & Biopharmaceutical Companies was $60.0 Million to $150.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-hydrophobic-interaction-chromatography-market-56734*